0001179110-11-006775.txt : 20110421 0001179110-11-006775.hdr.sgml : 20110421 20110421181834 ACCESSION NUMBER: 0001179110-11-006775 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110419 FILED AS OF DATE: 20110421 DATE AS OF CHANGE: 20110421 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Thomas Helmut CENTRAL INDEX KEY: 0001515616 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35119 FILM NUMBER: 11774384 MAIL ADDRESS: STREET 1: 4819 EMPEROR BOULEVARD STREET 2: SUITE 400 CITY: DURHAM STATE: NC ZIP: 27703 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TRANZYME INC CENTRAL INDEX KEY: 0001274644 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 631192270 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4819 EMPEROR BOULEVARD, SUITE 400 CITY: DURHAM STATE: NC ZIP: 27703 BUSINESS PHONE: 919 313-4760 MAIL ADDRESS: STREET 1: 4819 EMPEROR BOULEVARD, SUITE 400 CITY: DURHAM STATE: NC ZIP: 27703 4 1 edgar.xml FORM 4 - X0303 4 2011-04-19 0 0001274644 TRANZYME INC TZYM 0001515616 Thomas Helmut C/O TRANZYME, INC. 4819 EMPEROR BOULEVARD, SUITE 400 DURHAM NC 27703 0 1 0 0 Senior VP, R&D Stock Option (right to buy) 4.00 2011-04-19 4 A 0 78641 0 A 2021-04-19 Common Stock 78641 78641 D 25% of the shares will vest and become exercisable on April 19, 2012, with the remainder vesting and becoming exercisable in equal quarterly installments for the following 12 quarters thereafter. /s/ Richard I. Eisenstadt, attorney-in-fact 2011-04-21